Skip to main content
Leidos
Search
  • Suppliers
  • Employees
  • Newsroom
  • Investors
  • Global
  • Contact
  • Company
    • Our Business

      We embrace and solve some of the world's toughest challenges.

      • Civil
      • Defense
      • Health
      • Intelligence
      • Dynetics
      • Leidos Innovations Center (LInC)
      Tom Bell standing in a stairway at Leidos GHQ

      Leidos welcomes Tom Bell as incoming CEO.

      Meet Tom

    • Mission, Vision, & Values

      Everything we do is built on a commitment to do the right thing for our customers, our people, and our community.

      • Mission
      • Vision
      • Values
      man sitting on bleachers holding soccer ball

      Let’s come together and talk about the changes that are needed.

      The Opioid Epidemic: A Call to Action

    • Leadership

      Meet the executive team responsible for leading our forward-thinking employees toward a shared success.

      • Tom Bell
      • Chris Cage
      • Maureen Waterston
      • Vicki Schmanske
      • Jerry Howe
      • Jim Carlini
      • Debbie Opiekun
      • Thomas Sanglier
      • Jim Moos
      • Gerry Fasano
      • Roy Stevens
      • Liz Porter
      • Steve Cook
      • Paul Engola
      • Board of Directors
      Tom Bell standing in a stairway at Leidos GHQ

      Leidos welcomes Tom Bell as incoming CEO.

      Meet Tom

    • History

      Leidos has a long history of innovative problem-solving and customer service, dating all the way back to 1969 when Dr. J. Robert Beyster founded his "crazy little company".

      • Explore our History
      • Dr. J. Robert Beyster
      • A Kaleidoscope of Innovation: The Story of Leidos
      Dr. Beyster

      Almost 50 years ago, visionary scientist J. Robert Beyster, Ph.D. founded the company that evolved into Leidos.

      Read More

    • Diversity, Equity, & Inclusion

      Our commitment to diversity, equity, and inclusion is reflected in the way we engage our people, our customers, and our external partnerships through our innovative programs, sponsorships, and engagement.

      • Our Vision, Philosophy, and Approach
      • Strategic Diversity Outreach
      • Employee Resource Groups
      • Inclusion & Diversity in the UK
      Top Supporters HBCU badge for 2022

      Leidos was recently named to the 2022 Top Supporters of HBCU Engineering list published by Career Communications Group, Inc.

      Partnering with HBCUs

    • Responsibility & Sustainability

      We're equally committed to using our time and resources to support people, enrich communities, and protect the environment.

      • ESG Goals
      • CEO Message
      • Executive Summary
      • ESG Governance & Strategy
      • Environment
      • Community
      • People
      • Suppliers & Small Business Relationships
      • Political Activities
      • About our Reporting
      • GRI™ Standards
      NASA ground station

      Discover how we helped NASA develop a climate action plan

      Read Article

    • Ethics & Compliance

      We have a strong history of performance that rests on our foundation of integrity.

      • File a Report
      • History of Ethics
      • Ethics Program Structure
      • Code of Conduct
      World's most ethical companies logo

      Leidos named one of the World’s Most Ethical Companies for sixth consecutive year.

      Read More

    • Rankings & Awards

      Our innovative approach and the services and solutions we deliver frequently earn Leidos recognition from our industry and the media.

      • Enterprise Awards
      • Defense Awards
      • Civil Awards
      • Health Awards
      A gold trophy on a light green background

      A frequent honoree on the corporate awards circuit, Leidos is proud of its many industry-specific and corporate-level achievements.

      Cue the Applause

    • Partners

      The Leidos Alliance Partner Network emphasizes connections through partnership and collaboration that drive innovation, advance technology, and build efficiency.

      • Corporate Strategic Partners
      • Technology Integration Partners
      • Emerging Technology Partners
      Bubba Wallace image

      We're teaming up with Bubba Wallace and 23XI Racing in 2023 advancing a culture of inclusion and diversity.

      Fueling a Better Tomorrow

    • Subsidiaries

      Our wholly owned and majority-owned subsidiaries attract and retain top talent motivated to deliver results for clients.

      • 1901 Group
      • Dynetics
      • Gibbs & Cox
      • Leidos Biomedical Research
      • Leidos Digital Solutions
      • BEONTRA
      • QTC
      • Leidos Engineering
      • Systems Made Simple
      • Varec
      Gibbs & Cox-designed DDG-51 Arleigh Burke-class destroyer at sea

      Leidos completes Gibbs & Cox acquisition, expanding maritime undersea, autonomous and cybersecurity capabilities.

      Read Press Release

    • Contract Vehicles

      Whether you’re a potential government customer or a prospective supplier, through this listing you can find our technical and professional services under pre-negotiated terms and conditions.

      • Governmentwide MACs & IDIQs
      • GSA Schedules
      • Agency Specific IDIQs
      Leidos Lunar Terrain Vehicle

      Leidos and its Dynetics team will compete in another moon race, this time to design a vehicle that astronauts will use to explore the lunar surface.

      Take a lunar leap into the details

    • Global

      With more than 400 locations in 30 countries, we continue to expand our presence and strengthen our international relationships.

      • United Kingdom & Europe
      • Australia
      • Israel
      • Middle East
      • Canada
      plane flying over water

      Leidos has announced the completed acquisition of Cobham Aviation Services Australia’s Special Mission business.

      Hop Onboard to Learn More

    • Trust

      Cybersecurity and data privacy is central to what we do; protecting data, systems, and infrastructure that are critical to our employees, customers, communities, and stakeholders.

      • Commitment to Privacy & Cybersecurity
      • Cybersecurity
      • Data Privacy
      • Privacy Statement
      Citizens walking with data flowing around them

      Today, tomorrow, and every day is Data Privacy Day.

      Read the Article

  • Markets
    • Aviation

      From sidewalk to sky, we've got you covered.

      • Air Traffic Management
      • ANSP Professional Services
      • Security Solutions
      • Intelligent Approach
      • Scenario Planning & Forecasting
      • Passenger Flow Measurement
      • FODD & Fuels Management
      • Flight Management & Briefing
      Leidos Smartlane in use at an airport

      Safeguarding travel and trade at a global scale with fully-integrated security detection solutions.

      Learn About Our Portfolio

    • Defense

      Empowering and enabling mission success in all domains with aerial and autonomous platforms.

      • Advanced Manufacturing
      • Airborne
      • Autonomy & Autonomous Solutions
      • Command & Control
      • Cyber
      • Digital Modernization
      • Force Protection
      • Hypersonics & Strike Systems
      • JADC2
      • Operations & Logistics
      • Training
      Helicopter with a chest being carried underneath it

      Leidos was recently awarded a new prime contract to develop an uncrewed aircraft system that can autonomously resupply forward-deployed ground forces.

      Read Press Release

    • Energy & Industry

      Leidos is equipped to support critical industries like energy, transportation, and manufacturing.

      • Power Delivery
      • Integrated Energy Management
      • Electrification & Clean Energy Services
      • Project Finance & Development
      • Advanced Communications Solutions
      • Manufacturing Systems
      • Site Management & Operations
      • Transportation
      Electricity pylons in sunny field

      Leidos delivers a complex modeling project resulting in a clear view of bulk electric and sub-transmission systems for FirstEnergy.

      Read the Case Study

    • Government

      We support programs for identity theft recovery, health record protection, tax filing, fraud investigation, census data, and research.

      • Cybersecurity
      • Digital Modernization
      • Health IT
      • Forms Processing
      • Operations & Logistics
      • Mission Software Systems
      IT analysts in discussion over monitors

      Leidos completes acquisition of 1901 Group, expanding digital modernization capabilities.

      Read Press Release

    • Healthcare

      We draw on decades of success to deliver a range of solutions and services to meet the healthcare challenges of today.

      • Hospital Systems
      • Federal Health
      • Military & Veterans Health
      Healthcare professional using tablet

      Taking a strategic approach to experience true digital transformation in healthcare.

      Read White Paper

    • Homeland

      Integrating, applying, and advancing IT to tackle the ever-advancing challenges of protecting our borders.

      • Biometrics
      • Mission Cyber & Network Defense
      • Integrated Systems
      • Digital Modernization
      • Data Analytics
      • Intelligence & Linguistic Services
      • CBRN Defense
      • Human Capital Services
      • Complex Logistics
      • Ports & Borders
      • Critical Infrastructure
      Leidos Smartlane in use at an airport

      Safeguarding travel and trade at a global scale with fully-integrated security detection solutions.

      Learn About Our Portfolio

    • Intelligence

      With cloud-enabled automation and augmentation expertise and a team adept at harnessing machine learning, we apply powerful analytic tools for superior performance and data protection.

      • Intelligence Community Engineering
      • Collection, Analysis, & Reporting
      • Operational Support & Training
      Woman looking at computer screen reflection in glasses

      Our DevOps Lab is an advanced, unclassified, state-of-the-art center dedicated to software and hardware development and engineering.

      Learn more about the Lab

    • Science

      Groundbreaking scientific research and environmental management practices for defense, civilian, and health markets.

      • Life Sciences
      • Autonomous Systems
      • Airborne & Ground ISR
      • Command & Control
      • Environmental Science
      • Modeling, Simulation, & Training
      • Sensors
      • Specialty Sciences
      Illustration representing health-focused scientific research

      NCI's Frederick National Laboratory has launched three initiatives focused on SARS-CoV-2.

      Read the Article

    • Space

      Speed, security, and scale for your most critical space missions

      • Mission Operations
      • Human Exploration
      • ISR
      • Payloads
      • Domain Awareness
      • Propulsion
      Female behind a transparent screen with text and graphs visible

      IT systems disappear into the background by providing an enhanced user experience

      Learn how IT Enables the Mission

  • Capabilities
    • Cyber Operations

      We use intelligent automation and AI/ML to defend networks through detection and mitigation.

      • Quantum
      • Zero Trust
      • Security Operations Center
      • Cyber Resiliency
      • Risk Management Framework
      • Cyber Analytics
      • Information Assurance
      • Insider Threat
      • Accredited Testing & Evaluation
      • EXCITE
      • Electronic Warfare
      binary code

      Outpacing adversaries through the application of IT, engineering, and science.

      From Castles to Cities with Zero Trust

    • Digital Modernization

      Boost your IT resilience with trusted AI and full-spectrum cyber services for complex operations.

      • Application Modernization
      • Cloud
      • Data Center Modernization
      • Digital Workplace
      • Mobility
      • SecDevOps
      • User Engagement
      IT analysts in discussion over monitors

      Leidos completes acquisition of 1901 Group, expanding digital modernization capabilities.

      Read Press Release

    • Integrated Systems

      We deliver high-performing hardware and software systems to solve challenges in an array of specializations.

      • Assured-Position Navigation & Timing
      • Autonomous & Unmanned Systems
      • Biometrics
      • Security Detection & Automation
      • Sensors, Signal Processing, & Analysis
      • Space
      • Strike Systems & Hypersonics
      • TRAPS
      Female Leidos employee holding a tablet

      With the help of Leidos, IRS has been able to leverage enabling technology to develop solutions to the year's unique challenges.

      Read Article

    • Mission Operations

      Providing secure, resilient, and cost-effective tools and processes, informed by deep domain knowledge and mission understanding, to support critical customer missions.

      • Antarctic Support Contract
      • EngineeringEdge® NextGen
      • ISS Cargo Mission Contract
      • Leidos Performance Management
      • UK Logistics & Operations
      • StarTT®
      • Strategic National Stockpile
      Ice sheet in Antarctica

      Each year, Leidos moves more than six million pounds of cargo and coordinates 100 flight missions to and from Antarctica.

      About Our Role

    • Mission Software Systems

      Through disciplined processes, common tools, reusable frameworks, automation, collaboration, and domain expertise, our mission software systems are designed to deliver secure, mission quality software.

      • Command & Control
      • LEAF
      • SE Core
      • Tactical Data Links
      • AI/ML
      Software on a mission text on blue background

      Mission quality software. Silicon Valley speed.

      More on Building Better Software

    • Enabling Technologies

      Our enabling technologies are the backbone of our core capabilities, supporting our customer's important work from the front lines.

      • Secure, Rapid Software
      • Trusted AI/ML
      • Full-Spectrum Cyber
      • Rapid Prototyping & Manufacturing
      Military radar simulation with green display, showing a glowing grid with coordinates and positioning numbers

      How we are deploying AI to solve the world’s toughest problems.

      Artificial Intelligence in Action

    • Technology Certifications

      We partner with world-class technology providers to develop innovative solutions for our customer’s toughest challenges.

      • AWS
      • Cisco
      • Microsoft
      • Scaled Agile
      • ServiceNow
      group of coworkers looking at computer monitor

      We help our partners save money and improve performance.

      How the Cloud Saved Some Coin

  • Insights
    • Insights

      Get employees' and stakeholders' expertise, leadership, unique perspectives, and more.

      • Latest Insights
      • MindSET Podcast
      • Press Releases
      • Heroes of Leidos
      • Our Experts
      • Careers
      • Military & Veterans
      • Diversity, Equity, & Inclusion
      • Fact Sheets
      • Articles
      • Case Studies
      • Infographics
      • Q&As
      podcast microphone

      Listen to the stories behind the world's most important work in the MindSET podcast.

      Explore the MindSET Podcast

  • Careers
    • Latest Opportunities

      Keep up to date on the latest career opportunities at Leidos.

      • Military Veteran Program
      • External Referral Program
      • Intern & New Graduate Jobs
      • Careers with Leidos in the UK
      • Careers with Leidos in Australia
      • Opportunities for Leidos Employees
      People icons with gradient over

      At Leidos, we have a strong focus on our employees’ career, flexibility, and well-being.

      Learn more about Leidos Life

    • Life at Leidos

      A career at Leidos offers meaningful and engaging work, a collaborative culture, support for your career goals, while nurturing a healthy work-life balance.

      • Our Values
      • Our Culture
      • An Inclusive Workforce
      • Build a Career
      • Leidos Alumni Network
      People icons with gradient over

      At Leidos, we have a strong focus on our employees’ career, flexibility, and well-being.

      Learn more about Leidos Life

    • Pay & Benefits

      Pay and benefits are fundamental to any career decision, which is why our compensation packages reflect the importance of the work we do for our customers.

      • Compensation
      • Health & Wellness
      • Income Protection
      • Leave
      • Retirement
      • Family Benefits
      People icons with gradient over

      At Leidos, we have a strong focus on our employees’ career, flexibility, and well-being.

      Learn more about Leidos Life

    • Frequently Asked Questions

      Find answers to the most commonly asked questions related to securing a role at Leidos.

      • Searching for a Role
      • Applying for a Job
      • Determining Application Status
      • System Access
      • Job Eligibility Requirements
      • Receiving Job Notifications
      • Our Talent Community
      • Career Insights
      People icons with gradient over

      At Leidos, we have a strong focus on our employees’ career, flexibility, and well-being.

      Learn more about Leidos Life

  • Search Search
  • Company
  • Markets
  • Capabilities
  • Insights
  • Careers
Back to top

Breadcrumb

  1. Home
  2. Insights

Orgenesis and Leidos collaborate on potential treatment for COVID-19

GERMANTOWN, MD – June 22, 2020 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), today announces it has entered into a preliminary, non-binding term sheet with Leidos (“Leidos”) (NYSE: LDOS), a FORTUNE® 500 science and technology leader, to develop, and potentially obtain FDA marketing approval of Orgenesis’ Ranpirnase for the systemic treatment of patients suffering with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

Orgenesis recently acquired the assets of Tamir Biotechnology, Inc., including  Ranpirnase, a broad spectrum anti-viral agent. Ranpirnase catalyzes the degradation of RNA, and mediates several essential biological activities, including the regulation of cell proliferation, maturation, differentiation, and cell death.  Therefore, it is a potential candidate for the development of therapeutics for life-threatening diseases, including viral and autoimmune diseases, that require anti-proliferative and pro-apoptotic properties. Over 1,000 patients have been dosed with Ranpirnase in previous cancer/mesothelioma clinical trials.  Ranpirnase has already demonstrated a strong safety and tolerability profile.  Ranpirnase has also demonstrated preclinical antiviral activity in serious viral diseases, such as cytomegalovirus (CMV), influenza, HIV, Ebola, and SARS. This is based on its unique mechanism of action, which was shown to eradicate the virus and modulate the immune system in a series of in vitro studies.

Leidos conducted in vitro studies of Ranpirnase at the University of Tennessee Health Sciences Center Regional Biocontainment Laboratory (UTHSC RBL) and George Mason University National Center for Biodefense and Infectious Diseases (GMU NCBID) against the SARS CoV-2 virus. The in vitro studies demonstrated that Ranpirnase was significantly effective in killing the SARS CoV-2 virus – with an eight-fold average decrease in the number of plaque forming units when cultures with Ranpirnase were compared to the controls treated with a placebo. Based on these initial pre-clinical results, a pre-IND meeting request to fast track Ranpirnase for the treatment of SARS-COV-2 has been submitted by Leidos to the FDA.

Vered Caplan, CEO of Orgenesis, stated, “Based on the pre-clinical data, we are encouraged by the potential for Ranpirnase as an effective anti-viral therapy for SARS-COV-2. We believe this platform could address a significant need in the market and we look forward to leveraging Leidos’ expertise in development and clinical trial oversight, as well as relationships with government agencies, to possibly accelerate the development of Ranpirnase and its use as a potential treatment of patients with SARS-COV-2.”

Elizabeth Porter, Leidos Health Group president, said, “We are excited to team with Orgenesis for the development of Ranpirnase. We believe that this treatment has the potential to transform our understanding of SARS-COV-2 and provide new ways to fight this global pandemic. We look forward to collaborating with Orgenesis through each stage of the drug’s development.”

 

About Leidos

Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 37,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ended January 3, 2020. For more information, visit www.leidos.com.

 

About Orgenesis

Orgenesis is a pioneering global biotech company which is unlocking the full potential of personalized therapies and closed processing systems through its Cell & Gene Therapy Biotech Platform, with the ultimate aim of providing life changing treatments at the Point of Care to large numbers of patients at low cost. The Platform consists of: (a) POCare Therapeutics, a pipeline of licensed cell and gene therapies (CGTs), and proprietary scientific knowhow; (b) POCare Technologies, a suite of proprietary and in-licensed technologies which are engineered to create customized processing systems for affordable point of care therapies; and (c) POCare Network, a collaborative, international ecosystem of leading research institutes and hospitals committed to clinical development and supply of CGTs at the point of care. By combining science, technologies and a collaborative network, Orgenesis is able to identify the most promising new therapies and provide a pathway for them to reach patients more quickly, more efficiently and at scale, thereby unlocking the power of cell and gene therapy for all. Additional information is available at: www.orgenesis.com.

 

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. These forward-looking statements involve substantial uncertainties and risks and are based upon our current expectations, estimates and projections and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including, but not limited to, the risk that the acquisition of Tamir’s assets will not be successfully integrated with our technologies or that the potential benefits of the acquisition will not be realized, our ability to further develop ranpirnase following the acquisition, our reliance on, and our ability to grow, our point-of-care cell therapy platform, our ability to effectively use the net proceeds from the sale of Masthercell, our ability to achieve and maintain overall profitability, the development of our POCare strategy, the sufficiency of working capital to realize our business plans, the development of our transdifferentiation technology as therapeutic treatment for diabetes which could, if successful, be a cure for Type 1 Diabetes; our technology not functioning as expected; our ability to retain key employees; our ability to satisfy the rigorous regulatory requirements for new procedures; our competitors developing better or cheaper alternatives to our products and the risks and uncertainties discussed under the heading "RISK FACTORS" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31 2019, and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

Related Insights
View more Insights
  • Tom Bell in front of Leidos GHQ in Reston, Va.
    Tom Bell begins tenure as Leidos CEO
  • Leidos logo on a purple background
    Leidos Holdings, Inc. reports first quarter fiscal year 2023
  • A lunar rover with two astronauts onboard has its headlights as it travels through a purple background. Two logos announce a promotional partnership between Leidos and NASCAR.
    Leidos, NASCAR speed into lunar rover race
Author
Leidos logo
Media Relations

Media Contacts: 

Melissa Dueñas, Senior Vice President, Communications, +1 (571) 526-6850, [email protected]

Thomas Doheny, Director, Strategic Communications, +1 (571) 526-7601, [email protected]

Share
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share via Mail
  • Print Insight

Posted

June 21, 2020

Estimated Read Time

Author
Media Relations

Tags

News
Health

Sign up for our newsletters

Stay up to date on our expertise, industry leadership, unique perspectives, and more by subscribing to our newsletters.

  • Company
    • Our Business
    • Mission, Vision, & Values
    • Leadership
    • History
    • Diversity, Equity, & Inclusion
    • Responsibility & Sustainability
    • Ethics & Compliance
    • Rankings & Awards
    • Partners
    • Subsidiaries
    • Contract Vehicles
    • Global
    • Trust
  • Markets
    • Aviation
    • Defense
    • Energy & Industry
    • Government
    • Healthcare
    • Homeland
    • Intelligence
    • Science
    • Space
  • Capabilities
    • Cyber Operations
    • Digital Modernization
    • Integrated Systems
    • Mission Operations
    • Mission Software Systems
    • Enabling Technologies
    • Technology Certifications
  • Insights
    • Newsroom
  • Careers
    • Life at Leidos
    • Pay & Benefits
    • Alumni
    • FAQs

Want to know more?

Contact us about product information and pricing, customer feedback, stockholder services, or just to voice a concern.

Get started

  • © 2023 Leidos

  • Trust
  • Ad Choices

  • Privacy Statement
  • Email Preferences
  • Do Not Sell My Personal Information
  • © 2021 Leidos
  • Australian Privacy Statement
  • Australian Whistleblower Policy
  • Ad Choices
  • Email Preferences
  • Do Not Sell My Personal Information

Utility Footer Navigation

  • Products
  • Customers
  • Suppliers
  • Investors
  • Employees
  • Accessibility
  • Twitter
  • Facebook
  • Instagram
  • Linkedin
  • YouTube